You're offline - Playing from downloaded podcasts
Back to All Episodes
Podcast Episode

Oslo Patient Likely Cured of HIV After Brother's Stem Cell Transplant

April 14, 2026

0:00
4:09
Podcast Thumbnail

A sixty-three-year-old Norwegian man known as the Oslo patient has become roughly the tenth person in the world to achieve long-term HIV remission. He received a stem cell transplant from his brother, who happened to carry a rare genetic mutation that blocks the virus from entering immune cells. The findings were published in Nature Microbiology.

A Lucky Discovery Changes Everything

A Norwegian man known as the Oslo patient has been effectively cured of HIV after receiving a stem cell transplant from his brother, in what doctors are calling a remarkable stroke of medical fortune. The sixty-three-year-old, who had been living with HIV since 2006, is now roughly the tenth person in the world to achieve long-term remission from the virus.

From Cancer Treatment to HIV Cure

The patient was first diagnosed with HIV in 2006 and began antiretroviral therapy in 2010, which kept the virus under control. In 2017, he was diagnosed with myelodysplastic syndrome, a serious form of bone marrow cancer. After relapsing from drug treatment, doctors at Oslo University Hospital began searching for a bone marrow donor.

The medical team initially looked for an unrelated donor carrying the CCR5 delta thirty-two mutation, a genetic variant known from previous cure cases to prevent HIV from entering immune cells. When no compatible match was found, the patient's brother was selected as a donor to treat the cancer. It was only on the day of the transplant procedure in 2020 that doctors discovered the sibling carried two copies of the protective mutation.

No Trace of the Virus Remains

Two years after the transplant, the donated cells had completely replaced the patient's original immune cells in his blood, bone marrow, and gut. He was cleared to stop antiretroviral therapy, and four years after stopping medication, there has been no sign of viral rebound. Researchers collected sixty-five million CD four T cells and found none carrying virus capable of replicating.

A Stepping Stone, Not a Scalable Cure

Clinicians have emphasised that the procedure is not a viable treatment for the more than thirty million people living with HIV worldwide. Bone marrow transplants carry a mortality risk of ten to twenty percent within the first year and are performed only to treat life-threatening conditions such as cancer. However, the case adds to growing evidence that HIV can be eliminated from the body, offering hope that engineered therapies may one day allow broader populations to live without daily medication.

Published April 14, 2026 at 1:39pm

More Recent Episodes